ASHBURN, Va., May 02, 2023 (GLOBE NEWSWIRE) — Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (the “Company” or “Quoin”), a clinical stage specialty pharmaceutical company focused on rare and orphan diseases, announced today that the Company intends to release its first quarter 2023 financial results after the market closes on Monday, May 8, 2023. The Company will also host a conference call and webcast on May 9, 2023, at 8:30 am ET, to discuss the Company’s first quarter 2023 financial results and to provide a corporate update.
The live call can be accessed by dialing 1-877-270-2148 (domestic) or 1-412-902-6510 (international).
The live and archived webcast of the call will be available on the Quoin Pharmaceuticals website under the Investors section: https://investors.quoinpharma.com/news-and-events/events-and-presentations
About Quoin Pharmaceuticals Ltd.
Quoin Pharmaceuticals Ltd. is a clinical stage specialty pharmaceutical company focused on developing and commercializing therapeutic products that treat rare and orphan diseases. We are committed to addressing unmet medical needs for patients, their families, communities and care teams. Quoin’s innovative pipeline comprises four products in development that collectively have the potential to target a broad number of rare and orphan indications, including Netherton Syndrome, Peeling Skin Syndrome, Palmoplantar Keratoderma, Scleroderma, Epidermolysis Bullosa and others. For more information, visit: www.quoinpharma.com or LinkedIn for updates.
For further information, contact:
Investor Relations
PCG Advisory
Stephanie Prince
sprince@pcgadvisory.com
(646) 863-6341
R&D teams can streamline safety evaluations, reduce risks and enable faster decision-making in drug development…
Google Cloud helps streamline marketing processes, enhancing brand consistency and reducing operational costs AMSTERDAM and…
ZEIST, Netherlands, May 14, 2025 /PRNewswire/ -- Julius Clinical, a leading full-service Contract Research Organization (CRO)…
BEIJING, May 14, 2025 /PRNewswire/ -- SolarEast, a leading manufacturer of air-to-water heat pumps, has…
This award recognizes Avance Clinical's strategic innovation, operational agility, and unwavering commitment to client success in…
WEISER, Idaho, May 13, 2025 /PRNewswire/ -- Weiser Memorial Hospital ("WMH") is providing notice of…